Efficient sequence specific gene silencing of myeloid cell leukemia sequence 1 is possible through the use of siRNA technology. By selecting particular siRNAs directed to myeloid cell leukemia sequence 1 by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

 
Web www.patentalert.com

< Chemiluminescent compounds and their use

> Virulence of streptococci

> Test strip for a lateral flow assay for a sample containing whole cells

~ 00510